1. Home
  2. AMPH vs DGNX Comparison

AMPH vs DGNX Comparison

Compare AMPH & DGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • DGNX
  • Stock Information
  • Founded
  • AMPH 1996
  • DGNX 2018
  • Country
  • AMPH United States
  • DGNX United Kingdom
  • Employees
  • AMPH N/A
  • DGNX 26
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • DGNX
  • Sector
  • AMPH Health Care
  • DGNX
  • Exchange
  • AMPH Nasdaq
  • DGNX NYSE
  • Market Cap
  • AMPH 1.1B
  • DGNX 1.5B
  • IPO Year
  • AMPH 2014
  • DGNX 2025
  • Fundamental
  • Price
  • AMPH $20.54
  • DGNX $61.17
  • Analyst Decision
  • AMPH Hold
  • DGNX
  • Analyst Count
  • AMPH 5
  • DGNX 0
  • Target Price
  • AMPH $38.00
  • DGNX N/A
  • AVG Volume (30 Days)
  • AMPH 507.5K
  • DGNX 43.2K
  • Earning Date
  • AMPH 08-06-2025
  • DGNX 01-01-0001
  • Dividend Yield
  • AMPH N/A
  • DGNX N/A
  • EPS Growth
  • AMPH N/A
  • DGNX N/A
  • EPS
  • AMPH 2.77
  • DGNX N/A
  • Revenue
  • AMPH $730,659,000.00
  • DGNX $2,040,602.00
  • Revenue This Year
  • AMPH $0.67
  • DGNX N/A
  • Revenue Next Year
  • AMPH $5.18
  • DGNX N/A
  • P/E Ratio
  • AMPH $7.45
  • DGNX N/A
  • Revenue Growth
  • AMPH 8.05
  • DGNX 57.02
  • 52 Week Low
  • AMPH $20.45
  • DGNX $3.60
  • 52 Week High
  • AMPH $53.96
  • DGNX $155.00
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 36.57
  • DGNX N/A
  • Support Level
  • AMPH $21.09
  • DGNX N/A
  • Resistance Level
  • AMPH $22.31
  • DGNX N/A
  • Average True Range (ATR)
  • AMPH 0.75
  • DGNX 0.00
  • MACD
  • AMPH -0.08
  • DGNX 0.00
  • Stochastic Oscillator
  • AMPH 23.18
  • DGNX 0.00

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About DGNX DIGINEX LIMITED

Diginex Ltd is an investment holding company. It engaged in providing Environmental, Social, and Governance (ESG) reporting solution services, advisory services, and developing customization solutions. It is a sustainable RegTech business that empowers businesses and governments to streamline ESG, climate, and supply chain data collection and reporting. The company utilizes blockchain, AI, machine learning, and data analysis technology to change and increase corporate regulatory reporting and sustainable finance transparency. Its solutions and services enable companies to collect, evaluate, and share sustainability data through easy-to-use software.

Share on Social Networks: